首页> 外国专利> 2 617 Methods primers and kits for quantitative detection of JAK2 V617F mutants using pyrosequencing

2 617 Methods primers and kits for quantitative detection of JAK2 V617F mutants using pyrosequencing

机译:2 617种方法的引物和试剂盒,用于使用焦磷酸测序法定量检测JAK2 V617F突变体

摘要

A method for detecting a JAK2 V617F mutant is provided to easily, sensitively, accurately and quantitatively detect the JAK2 V617F mutant through pyrosequencing with good reproducibility and reduced time and cost, thereby being used for diagnosing, prognosing, and estimating the treatment progress of various lymphoblastic blood diseases such as chronic myeloid diseases, myeloproliferative diseases and myeloid metaplasia. A method for quantitatively detecting a JAK2 V617F mutant comprises the steps of: (a) subjecting a total DNA extracted by using a forward primer of SEQ ID : NO. 1 and a reverse primer of SEQ ID : NO. 4 to a PCR; and (b) subjecting the obtained PCR product to a pyrosequencing using a sequence analyzing primer of SEQ ID : NO. 5. A kit for quantitatively detecting a JAK2 V617F mutant comprises a forward and a reverse primers of PCR, respectively having a sequence of SEQ ID : NO. 1 and 4, for performing pyrosequencing, and a sequence analysis primer of the pyrosequencing having a sequence of SEQ ID : NO. 5.
机译:本发明提供了一种JAK2 V617F突变体的检测方法,可通过焦磷酸测序轻松,灵敏,准确,定量地检测JAK2 V617F突变体,具有良好的重现性,并减少了时间和成本,从而可用于诊断,预测和估计各种淋巴细胞的治疗进展。血液疾病,例如慢性髓样疾病,骨髓增生性疾病和髓样化生。一种定量检测JAK2 V617F突变体的方法,其包括以下步骤:(a)对通过使用SEQ ID NO:1的正向引物提取的总DNA进行处理。 1和SEQ ID NO:1的反向引物。 4进行PCR; (b)使用SEQ ID NO:1的序列分析引物对获得的PCR产物进行焦磷酸测序。 5.一种用于定量检测JAK2 V617F突变体的试剂盒,其包含分别具有SEQ ID NO:1的序列的PCR的正向和反向引物。参照图1和图4,进行焦磷酸测序,以及焦磷酸测序的序列分析引物,其序列为SEQ ID NO:1。 5,

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号